D05.80 — Other specified type of carcinoma in situ of unspecified breastICD-10-CM
No Prior Auth Required
Code is covered without prior authorization (high confidence)
A58756 — Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J05
L39040 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J05
L35000 — Molecular Pathology Procedures
J06
A59926 — Billing and Coding: Molecular Pathology Procedures
J06
Ask Verity about documentation requirements, denial risks, or coverage in your state.
A56199 — Billing and Coding: Molecular Pathology Procedures
J06
A57449 — Billing and Coding: BRCA1 and BRCA2 Genetic Testing
J09
L36499 — BRCA1 and BRCA2 Genetic Testing
J09
A52478 — External Breast Prostheses - Policy Article
J19
A58734 — Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58681 — Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A59160 — Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
A58679 — Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
L38966 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
L38972 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
L38974 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
L39017 — MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58652 — Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A57788 — Billing and Coding: Peripheral Nerve Blocks
L33933 — Peripheral Nerve Blocks
L39387 — Luteinizing Hormone-Releasing Hormone (LHRH) Analogs